Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
Pharmaceutical Statistics
|
May 25, 2023
Bayesian borrowing from historical control data in a vaccine efficacy trial
Lin Peng, Jing Jin, Laurent Chambonneau, et al.
Clinical Therapeutics
|
September 1, 2004
A randomized, open-label study of the immunogenicity and reactogenicity of three lots of a combined typhoid fever/hepatitis A vaccine in healthy adults
Micha Loebermann, Herwig Kollaritsch, Tom Ziegler, et al.
Journal of Travel Medicine
|
December 14, 2005
Combined typhoid fever and hepatitis A vaccine: comparison of immunogenicity and safety to concomitant monovalent vaccine over 3 years
David Overbosch, François Peyron, Nicole Picot, et al.
The Journal of Infectious Diseases
|
July 16, 2016
Tetravalent Dengue Vaccine Reduces Symptomatic and Asymptomatic Dengue Virus Infections in Healthy Children and Adolescents Aged 2-16 Years in Asia and Latin America
Gustavo Olivera-Botello, Laurent Coudeville, Karen Fanouillere, et al.
The Journal of Infectious Diseases
|
June 26, 2021
Analysis of Neutralizing Antibodies as a Correlate of Instantaneous Risk of Hospitalized Dengue in Placebo Recipients of Dengue Vaccine Efficacy Trials
Ying Huang, Brian D Williamson, Zoe Moodie, et al.
The Pediatric Infectious Disease Journal
|
March 25, 2008
Age-specific prevalence of dengue antibodies in Bangkok infants and children
Krisana Pengsaa, Kriengsak Limkittikul, Christine Luxemburger, et al.
The Journal of Infectious Diseases
|
November 4, 2006
Dengue virus infections in the first 2 years of life and the kinetics of transplacentally transferred dengue neutralizing antibodies in thai children
Krisana Pengsaa, Christine Luxemburger, Arunee Sabchareon, et al.
Vaccine
|
April 25, 2006
Innate and adaptive cellular immunity in flavivirus-naïve human recipients of a live-attenuated dengue serotype 3 vaccine produced in Vero cells (VDV3)
Violette Sanchez, Sophie Gimenez, Brian Tomlinson, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene
|
December 28, 2020
Immunobridging efficacy of a tetravalent dengue vaccine against dengue and against hospitalized dengue from children/adolescents to adults in highly endemic countries
Ying Huang, Zoe Moodie, Michal Juraska, et al.
Vaccine
|
August 18, 2015
Lot-to-lot consistency of a tetravalent dengue vaccine in healthy adults in Australia: a randomised study
Joseph Torresi, Leon G Heron, Ming Qiao, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
Pharmaceutical Statistics
|
May 25, 2023
Bayesian borrowing from historical control data in a vaccine efficacy trial
Lin Peng, Jing Jin, Laurent Chambonneau, et al.
Clinical Therapeutics
|
September 1, 2004
A randomized, open-label study of the immunogenicity and reactogenicity of three lots of a combined typhoid fever/hepatitis A vaccine in healthy adults
Micha Loebermann, Herwig Kollaritsch, Tom Ziegler, et al.
Journal of Travel Medicine
|
December 14, 2005
Combined typhoid fever and hepatitis A vaccine: comparison of immunogenicity and safety to concomitant monovalent vaccine over 3 years
David Overbosch, François Peyron, Nicole Picot, et al.
The Journal of Infectious Diseases
|
July 16, 2016
Tetravalent Dengue Vaccine Reduces Symptomatic and Asymptomatic Dengue Virus Infections in Healthy Children and Adolescents Aged 2-16 Years in Asia and Latin America
Gustavo Olivera-Botello, Laurent Coudeville, Karen Fanouillere, et al.
The Journal of Infectious Diseases
|
June 26, 2021
Analysis of Neutralizing Antibodies as a Correlate of Instantaneous Risk of Hospitalized Dengue in Placebo Recipients of Dengue Vaccine Efficacy Trials
Ying Huang, Brian D Williamson, Zoe Moodie, et al.
The Pediatric Infectious Disease Journal
|
March 25, 2008
Age-specific prevalence of dengue antibodies in Bangkok infants and children
Krisana Pengsaa, Kriengsak Limkittikul, Christine Luxemburger, et al.
The Journal of Infectious Diseases
|
November 4, 2006
Dengue virus infections in the first 2 years of life and the kinetics of transplacentally transferred dengue neutralizing antibodies in thai children
Krisana Pengsaa, Christine Luxemburger, Arunee Sabchareon, et al.
Vaccine
|
April 25, 2006
Innate and adaptive cellular immunity in flavivirus-naïve human recipients of a live-attenuated dengue serotype 3 vaccine produced in Vero cells (VDV3)
Violette Sanchez, Sophie Gimenez, Brian Tomlinson, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene
|
December 28, 2020
Immunobridging efficacy of a tetravalent dengue vaccine against dengue and against hospitalized dengue from children/adolescents to adults in highly endemic countries
Ying Huang, Zoe Moodie, Michal Juraska, et al.
Vaccine
|
August 18, 2015
Lot-to-lot consistency of a tetravalent dengue vaccine in healthy adults in Australia: a randomised study
Joseph Torresi, Leon G Heron, Ming Qiao, et al.
Page
of 2